ResearcherThird Xiangya HospitalActive in the last 2 years
Yang Liu
Matched on ORCID iD 0000-0003-4559-5119; OpenAlex author ID A5100381109. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2021: 2 papers · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 3
- MMP28 promotes tumorigenesis and gemcitabine resistance in pancreatic cancer by promoting glycolysis through interaction with SND1. Co-author DOI 10.1016/j.bcp.2025.117556↗
- Over-expressed RHEB promotes the progression of pancreatic adenocarcinoma. Co-author DOI 10.1016/j.lfs.2021.119462↗
- Multi-Omics Analysis of Anlotinib in Pancreatic Cancer and Development of an Anlotinib-Related Prognostic Signature. First author DOI 10.3389/fcell.2021.649265↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Juan Tan · 3 shared papers, 2021–2026 · strength 0.58
- Paper MMP28 promotes tumorigenesis and gemcitabine resistance in pancreatic cancer by promoting glycolysis through interactio… DOI 10.1016/j.bcp.2025.117556↗
- Paper Over-expressed RHEB promotes the progression of pancreatic adenocarcinoma. DOI 10.1016/j.lfs.2021.119462↗
- Paper Multi-Omics Analysis of Anlotinib in Pancreatic Cancer and Development of an Anlotinib-Related Prognostic Signature. DOI 10.3389/fcell.2021.649265↗
- Zewen Song · 2 shared papers, 2021 · strength 0.29
- Xi Zhang · 1 shared paper, 2021 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.